CellVax Therapeutics Inc

CellVax Therapeutics Inc. is a privately-held clinical-stage company headquartered in Miami, Florida. With a team of three employees, CellVax Therapeutics focuses its efforts on research, development, and innovation in the field of individualized cell-based immunotherapies. The company specializes in developing a proprietary autologous tumor cell-based cancer immuno-therapy platform. This platform involves creating a treatment from a patient's own tumor cells, which then stimulates the immune system to recognize and destroy cancerous cells. CellVax Therapeutics stands out as a pioneer in developing this type of autologous cell treatment, aiming to generate a strong and targeted immune response against cancer. For more information about CellVax Therapeutics Inc. and their innovative cancer treatment approach, please visit their website at cellvx.com.